An image of the brain created from multiple images of different pictures of retinas (back of the eye) with different diseases. Copyright Jon Brett.

About The Founder

Jolly Vision Science was started by Dr Jasleen Jolly DPhil MSc FCOptom, Associate Professor in Vision Science.

Dr Jolly is standing in front of wooden steps. She is dressed in a black academic gown with yellow and white trim, hair tied back, dark blue glasses, green turtle neck shirt and green earrings. Dr Jolly is holding a framed award certificate with a big smile.

Dr Jolly is working on multiple clinical trials for novel therapies including gene therapy with a range of institutions. These includes Oxford University, University of Cambridge, and University of Melbourne. From this work Dr Jolly realised that one of the key problems that causes prevention of new therapies from being translated into clinical care is poor choice of outcome measures that means the trials do not meet their objectives. To combat this Dr Jolly’s clinical studies have focused on developing novel and scientifically driven outcome measures that are more fit for purpose. This will combat funding and effort waste and increase success rate of translation for new therapies.

Dr Jolly continually advocates for patients and has led a number of projects to capture their experience of health and participating in scientific research. Patients are not only patients, they are very talented member of society. They are our loved ones, our friends, our colleagues, who all have skills and knowledge we can learn from so workplaces must be made accessible in order to benefit from a wide range of voices and experiences to enhance the work we do.

Dr Jolly completed a Masters in Investigative Ophthalmology and Vision Science (Distinction) at Manchester University and then did a DPhil (PhD) at the University of Oxford in Clinical Neuroscience whilst working in Professor MacLaren’s team on the Oxford gene therapy programme. Her PhD was funded via a prestigious National Institute of Health Research (NIHR) fellowship and was between 2 departments in Oxford, as well as continuing clinical work in Oxford Eye Hospital. The final thesis was half dedicated to the optimisation of outcome measures in gene therapy trials, and the other half examining impact of photoreceptor disease on the visual pathways into the brain. Dr Jolly’s current work combines ophthalmology, optometry, neuroscience, neurology and psychology. Dr Jolly is a member of multiple international committees leading the development of standards for future practice and has been involved in regulatory approvals.

My Memberships

error: Content is protected !!
Scroll to Top